Literature DB >> 7029182

Mechanism of adriamycin cardiotoxicity: evidence for oxidative stress.

R D Olson, R C Boerth, J G Gerber, A S Nies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7029182     DOI： 10.1016/0024-3205(81)90001-1

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  31 in total

1.  Effects of pirarubicin, an antitumor antibiotic, on the cardiovascular system.

Authors:  S Hirano; N Agata; Y Hara; H Iguchi; M Shirai; H Tone; N Urakawa
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Is the combinational administration of doxorubicin and glutathione a reasonable proposal?

Authors:  Bo-Yu Shen; Chong Chen; Yang-Fan Xu; Jia-Jia Shen; Hui-Min Guo; Hao-Feng Li; Xi-Nuo Li; Dian Kang; Yu-Hao Shao; Zhang-Pei Zhu; Xiao-Xi Yin; Lin Xie; Guang-Ji Wang; Yan Liang
Journal:  Acta Pharmacol Sin       Date:  2018-09-14       Impact factor: 6.150

3.  Effects of adriamycin on chronic cardiotoxicity in selenium-deficient rats.

Authors:  C Coudray; S Mouhieddine; M J Richard; J Arnaud; J De Leiris; A Favier
Journal:  Basic Res Cardiol       Date:  1992 Mar-Apr       Impact factor: 17.165

4.  Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity.

Authors:  Y J Kang; Y Chen; A Yu; M Voss-McCowan; P N Epstein
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

5.  Time-related increases in cardiac concentrations of doxorubicinol could interact with doxorubicin to depress myocardial contractile function.

Authors:  P S Mushlin; B J Cusack; R J Boucek; T Andrejuk; X Li; R D Olson
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

6.  Cardiovascular autonomic function in anthracycline-treated breast cancer patients.

Authors:  M Viniegra; M Marchetti; M Losso; A Navigante; S Litovska; A Senderowicz; L Borghi; J Lebron; D Pujato; H Marrero
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

7.  The effect of chronic adriamycin treatment on heart kidney and liver tissue of male and female rat.

Authors:  R H Julicher; L Sterrenberg; G R Haenen; A Bast; J Noordhoek
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

Review 8.  Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.

Authors:  V Ashutosh Rao
Journal:  Antioxid Redox Signal       Date:  2012-10-26       Impact factor: 8.401

Review 9.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

Review 10.  Environmentally responsive peptides as anticancer drug carriers.

Authors:  Suhaas Aluri; Siti M Janib; J Andrew Mackay
Journal:  Adv Drug Deliv Rev       Date:  2009-07-20       Impact factor: 15.470
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.